The Federal Register

Meeting of the Citizens' Health Care Working Group

Wed, Dec 7 2005 11:00:00 GMT

In accordance with section 10(a) of the Federal Advisory Committee Act, this notice announces a meeting of the Citizens' Health Care Working Group (the Working Group) mandated by section 1014 of the Medicare Modernization Act.

Notice of Meeting

Wed, Dec 7 2005 11:00:00 GMT

In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting.

A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Health Care Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for ``Small Research Grants for Primary Care PracticeBased Re

Statement of Organization, Functions, and Delegations of Authority

Wed, Dec 7 2005 11:00:00 GMT

Part T (Agency for Toxic Substances and Disease Registry) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (50 FR 2512925130, dated June 17, 1985, as amended most recently at 70 FR 59350, dated October 12, 2005) is amended to reflect the reorganization of the Agency for Toxic Substances and Disease Registry (ATSDR).

Section TB, Organization and Functions, is hereby amended as follows:

Delete in its entirety the title and functional statements for the Program Services Activity (TV612), Division of Health Assessment and Consultation (TB6).

Delete in its entirety the functional statement for the Community Involvement Branch (TB67), and insert the following:

Health Promotion and Community Involvement Branch (TB67). (1) Plans, directs, coordinates and implements the division's health promotion and community involvement program; communicates ATSDR's roles and responsibilities to communities and tribes; and, prov

Notice of the Revised Priority List of Hazardous Substances That Will Be the Subject of Toxicological Profiles

Wed, Dec 7 2005 11:00:00 GMT

The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA or Superfund), as amended by the Superfund Amendments and Reauthorization Act (SARA), requires that ATSDR and the Environmental Protection Agency (EPA) revise the Priority List of Hazardous Substances. This list includes substances most commonly found at facilities on the CERCLA National Priorities List (NPL) which have been determined to be of greatest concern to public health at or around these NPL hazardous waste sites. This announcement provides notice that the agencies have developed and are making available a revised CERCLA Priority List of 275 Hazardous Substances, based on the most recent information available. Each substance on the priority list is a candidate to become the subject of a toxicological profile prepared by ATSDR and
[[Page 72841]]
subsequently a candidate for the identification of priority data needs.

In addition to the Priority List of Hazardous Substances, ATSDR has developed a Complete

Statement of Organization, Functions, and Delegations of Authority

Wed, Dec 7 2005 11:00:00 GMT

Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 6777276, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 70 FR 7061718, dated November 22, 2005) is amended to reflect the reorganization of the Facilities Planning and Management Office, within the Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

Section CB, Organization and Functions, is hereby amended as follows:

Delete in its entirety the titles and functional statements for the Facilities Planning and Management Office (CAJ3) and insert the following:

Buildings and Facilities Office (CAJC). (1) Operates, maintains, repairs, and modifies CDC's Atlanta area plant facilities, and conducts a maintenance and repair program for CDC's program support equipment; (2) carries out facilities planning functions for CDC, inclu

Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; MedWatch: Food

Wed, Dec 7 2005 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``MedWatch: Food and Drug Administration Medical Products Reporting Program'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Industry Exchange Workshop on Food and Drug Administration Clinical Trial Requirements; Public Workshop; Amendment of

Wed, Dec 7 2005 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing an amendment to the notice of public workshop on FDA clinical trial statutory and regulatory requirements. This workshop was announced in the Federal Register of September 21, 2005 (70 FR 55405). The amendment is made to reflect a change in the Location portion of the document. There are no other changes.

Risk Management, Corrective and Preventive Actions, and Training: An Educational Forum; Public Workshop

Wed, Dec 7 2005 11:00:00 GMT

The Food and Drug Administration (FDA), Office of Regulatory Affairs, Southwest Region, Dallas District Office, in collaboration with the FDA Medical Device Industry Coalition (FMDIC) is announcing a public workshop entitled ``Risk Management, Corrective and Preventive Actions, and Training: An Educational Forum.'' This public workshop is intended to provide information about FDA's medical device quality systems regulation (QSR) to regulated industry, particularly small businesses.

Date and Time: The public workshop will be held on April 28, 2006, from 8 a.m. to 5 p.m.

Location: The public workshop will be held at The Westin City Center, 650 North Pearl St., Dallas, TX 75201. Directions to the facility are available at the FMDIC Web site at http://www.fmdic.org/.

Contact Person: David Arvelo or Cassandra Davis, Food and Drug Administration, 4040 North Central Expres

Advisory Commission on Childhood Vaccines; Notice of Meeting

Wed, Dec 7 2005 11:00:00 GMT

The Health Resources and Services Administration published a notice in the Federal Register of November 22, 2005 (70 FR 70623) announcing an Advisory Commission on Childhood Vaccines meeting on December 12, 2005. The document announced that the public can join the meeting by attending in person or by audio conference call. The meeting will now be held by audio conference call only. This document amends the notice by changing the place of the meeting.